These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19442516)

  • 21. Prostate cancer--are ethnic minorities disadvantaged?
    Lamb DS; Bupha-Intr O; Bethwaite P; Murray J; Nacey J; Russell G; Delahunt B
    Anticancer Res; 2008; 28(6B):3891-5. PubMed ID: 19192646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of localised prostate cancer].
    Jakobsen H; Iversen P; Mikines KJ; Nørgaard N; Høyer M
    Ugeskr Laeger; 2007 May; 169(20):1902-4. PubMed ID: 17553367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-dose-rate brachytherapy for localized prostate adenocarcinoma post abdominoperineal resection of the rectum and pelvic irradiation: Technique and experience.
    Jabbari S; Hsu IC; Kawakami J; Weinberg VK; Speight JL; Gottschalk AR; Roach M; Shinohara K
    Brachytherapy; 2009; 8(4):339-44. PubMed ID: 19428310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The clinical significance and therapeutic implications of extraprostatic invasion.
    Foley CL; Feneley MR
    Surg Oncol; 2009 Sep; 18(3):203-12. PubMed ID: 19398328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Brachytherapy for localised prostate cancer].
    Peiffert D
    Cancer Radiother; 2007 Nov; 11(6-7):373-8. PubMed ID: 17962060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [T1-T2 prostate cancer: treatment by radiation therapy].
    Lagrange JL; Guerif S
    Bull Cancer; 2007 Jul; 94(7 Suppl):F5-14. PubMed ID: 17845988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monotherapy for stage T1-T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent seed implantation.
    McAleese J; O'Sullivan JM
    Radiother Oncol; 2005 Apr; 75(1):121. PubMed ID: 15878111
    [No Abstract]   [Full Text] [Related]  

  • 28. Postradiotherapy 2-year prostate-specific antigen nadir as a predictor of long-term prostate cancer mortality.
    Zelefsky MJ; Shi W; Yamada Y; Kollmeier MA; Cox B; Park J; Seshan VE
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1350-6. PubMed ID: 19515504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Permanent prostate seed brachytherapy: a current perspective on the evolution of the technique and its application.
    Sahgal A; Roach M
    Nat Clin Pract Urol; 2007 Dec; 4(12):658-70. PubMed ID: 18059346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast.
    Trombetta M; Julian TB; Werts DE; McWilliams W; Kim Y; Miften M; Parda D
    Am J Clin Oncol; 2009 Jun; 32(3):314-8. PubMed ID: 19451803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer.
    Gore JL; Kwan L; Lee SP; Reiter RE; Litwin MS
    J Natl Cancer Inst; 2009 Jun; 101(12):888-92. PubMed ID: 19509365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Technical acquisition and dosimetric assessment of iodine-125 permanent brachytherapy in localized prostate cancer: our first series of 100 patients.
    Tanaka N; Asakawa I; Kondo H; Tanaka M; Fujimoto K; Hasegawa M; Konishi N; Hirao Y
    Int J Urol; 2009 Jan; 16(1):70-4. PubMed ID: 19120529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prostate cancer: what role for curative radiotherapy in elderly?].
    Nguyen TD; Azria D; Brochon D; Poortmans P; Miller RC
    Cancer Radiother; 2009 Oct; 13(6-7):623-7. PubMed ID: 19695936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel treatment methods for localized prostate cancer: hypofractionated robotic radiation therapy and adjuvant chemotherapy.
    Dawson NA; Collins SP
    Expert Rev Anticancer Ther; 2009 Jul; 9(7):953-62. PubMed ID: 19589034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Chronic gastrointestinal toxicity after external-beam radiation therapy for prostate cancer].
    Sefrová J; Paluska P; Odrázka K; Jirkovský V
    Klin Onkol; 2009; 22(5):233-41. PubMed ID: 19886362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Definitive conformal radiotherapy for localized prostate cancer: a long-term follow-up study.
    Deichmueller CM; Wegener G; Karstens JH; Bruns F
    Anticancer Res; 2009 Jul; 29(7):2627-34. PubMed ID: 19596938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized trial of external beam radiotherapy versus cryoablation in patients with localized prostate cancer: quality of life outcomes.
    Robinson JW; Donnelly BJ; Siever JE; Saliken JC; Ernst SD; Rewcastle JC; Trpkov K; Lau H; Scott C; Thomas B
    Cancer; 2009 Oct; 115(20):4695-704. PubMed ID: 19691092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New aspects in prostate cancer therapy].
    Dvorácek J
    Cas Lek Cesk; 2007; 146(10):736-45. PubMed ID: 18020004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic therapies for non-metastatic prostate cancer: review of the literature.
    Jereczek-Fossa BA; Curigliano G; Orecchia R
    Onkologie; 2009 Jun; 32(6):359-63. PubMed ID: 19521126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Anaemia and prostatic cancer].
    Boustany R; Zerbib M
    Prog Urol; 2005 Sep; 15(4):604-10. PubMed ID: 16459671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.